title: [Is the prostate cancer screening behaviour of men with familial predisposition predictable?].
abstract: Little is known about the motives of German men to attend or refuse preventive checkups for prostate cancer. The aims of this study were to investigate if in men with familial predisposition screening behaviours are influenced by epidemiological or clinical parameters of prostate cancer of their affected relatives. 476 probands with one and 312 probands with at least two affected relatives were advised in writing to have a PSA-test and DRE done at their local urologists. We evaluated if the response rate was correlated to the proband's age, to the number and the age of onset of their affected relatives and also to the clinical course of their disease. Our data implicate that in men with familial predisposition the acceptance of prostate cancer screening is influenced only by individual characteristics and personal attitude and not by factors within the family. To which extent the awareness of disease risk is modified by familial predisposition remains to be evaluated.
authors.affiliation: Abteilung der Urologie und Kinderurologie, Urologische Universitätsklinik und Poliklinik, Ulm. thomas.paiss@medizin.uni-ulm.de
authors.forename: T
authors.initials: T
authors.lastname: Paiss
authors.forename: D
authors.initials: D
authors.lastname: Kahn
authors.forename: R
authors.initials: R
authors.lastname: Küfer
authors.forename: C
authors.initials: C
authors.lastname: Maier
authors.forename: W
authors.initials: W
authors.lastname: Vogel
authors.forename: J E
authors.initials: JE
authors.lastname: Gschwend
authors.forename: R E
authors.initials: RE
authors.lastname: Hautmann
authors.forename: K
authors.initials: K
authors.lastname: Herkommer
mesh_terms: D000328:Adult; D000368:Aged; D020022:Genetic Predisposition to Disease / Q000453:epidemiology*; D005820:Genetic Testing / Q000706:statistics & numerical data*; D005858:Germany / Q000453:epidemiology; D006801:Humans; D008297:Male; D008875:Middle Aged; D010349:Patient Compliance / Q000706:statistics & numerical data*; D011471:Prostatic Neoplasms / Q000175:diagnosis* / Q000453:epidemiology* / Q000235:genetics / Q000517:prevention & control; D018570:Risk Assessment / Q000379:methods*; D012307:Risk Factors
references.citation: Arch Fam Med. 1997 Sep-Oct;6(5):453-8
references.pmid: 9305688
references.citation: J Abnorm Psychol. 1953 Jan;48(1):78-92
references.pmid: 13022199
references.citation: Oncology (Williston Park). 2000 Feb;14(2):267-72, 277-8, 280 passim
references.pmid: 10736812
references.citation: Eur Urol. 2003 Sep;44(3):294-302
references.pmid: 12932926
references.citation: J Public Health Med. 2000 Sep;22(3):312-6
references.pmid: 11077903
references.citation: Cancer Epidemiol Biomarkers Prev. 2004 May;13(5):753-8
references.pmid: 15159306
references.citation: Nurse Pract. 1997 Jan;22(1):17, 151
references.pmid: 9004310
references.citation: Cancer. 2002 Sep 1;95(5):1037-44
references.pmid: 12209688
references.citation: Urology. 2003 Jan;61(1):20-2
references.pmid: 12559259
references.citation: Am J Prev Med. 1998 Jul;15(1):81-4
references.pmid: 9651646
references.citation: Cancer. 1999 Mar 15;85(6):1305-12
references.pmid: 10189136
references.citation: J Behav Med. 2001 Jun;24(3):247-58
references.pmid: 11436545
references.citation: Prev Med. 2000 Sep;31(3):195-202
references.pmid: 10964632
references.citation: Ann Intern Med. 2002 Dec 3;137(11):917-29
references.pmid: 12458993
references.citation: CA Cancer J Clin. 2003 Jan-Feb;53(1):27-43
references.pmid: 12568442
references.citation: Urologe A. 2002 Jan;41(1):38-43
references.pmid: 11963773
references.citation: Urologe A. 2002 Nov;41(6):596-601
references.pmid: 12524947
references.citation: Cancer Epidemiol Biomarkers Prev. 1998 Jul;7(7):627-30
references.pmid: 9681532